Less than two years af­ter nine-fig­ure IPO, Ap­plied Mol­e­c­u­lar Trans­port cuts back on staff, pipeline ef­forts

An­oth­er day, an­oth­er biotech un­der­go­ing a sig­nif­i­cant shift thanks to the bear mar­ket.

Wednes­day’s vic­tim is Ap­plied Mol­e­c­u­lar Trans­port. This morn­ing the San Fran­cis­co-based biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER